Prime Medicine Inc (NASDAQ:PRME) currently has a daily average trading volume of 1.81M but it saw 3932724 shares traded in last market. With a market cap of 152.96M USD, the company’s current market price of $1.16 came falling about -0.85 while comparing to the previous closing price of $1.17. In past 52 weeks, the stock remained buoying in the range of price level as high as $8.27 and as low as $1.11.
JMP Securities issued its recommendations for the stock as it initiated the price target for the stock is $10.
Over the week, PRME’s stock price is moving -3.72% down while it is -31.07% when we observe its performance for the past one month. Year-to-date it is -60.10% down and over the past year, the stock is showing a downside performance of -83.55%.
The company is expected to be releasing its next quarterly report in June, for which analysts forecasted an EPS of -0.34 while estimate for next year EPS is -1.22. In next quarter, company is expected to be making quarterly sales of $2.79M as analysts are expecting the sales for current fiscal year at $15.56M and seeing the company making $33.03M in sales next year. Moreover, analysts are in estimates of $2.33M for current-quarter revenue.
Currently, Prime Medicine Inc’s total number of outstanding shares is 131.16M with 24.07% of that held by the insiders while 56.57% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -91.32% and return on equity (ROE) at -115.21%. Stock’s beta reads 1.64. Stock has a price to book (P/B) ratio of 1.43 while price to sale or P/S ratio amounts to 39.73. Its return on asset (ROA) is -63.17% on average.
